Welcome to Genable Technologies

Genable is a specialty biotech company spun out of Trinity College Dublin with significant backing from venture capital investors and a management team with a proven track record of achievements.

Current focus

Genable is commercializing a suite of gene based technologies with the potential to treat more than 100 presently incurable genetic disorders.

The Company's current market focus is on two orphan indications - retinitis pigmentosa and osteogenesis imperfecta.

Genable's underlying platform technology may be applied to a broad range of "dominant" genetic diseases and is currently being made available for licensing to select industry partners.

Patents

Genable controls a broad suite of granted patents and patent applications in the USA, EU and worldwide which open entirely new markets previously ignored due to a lack of appropriate technology. Genable now presents the opportunity to tap this multi-billion euro markets characterised by significant unmet clinical need.